Juha P Himanen (Juha Himanen)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Papillary Thyroid

Subarachnoid Hemorrhage

Top Venues

Science (New York, N.Y.)

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaojun Shi, Ryan Lingerak, Cameron J Herting, Yifan Ge, Soyeon Kim, Paul Toth, Wei Wang, Benjamin P Brown, Jens Meiler, Khalid Sossey-Alaoui, Matthias Buck, Juha P Himanen, Dolores Hambardzumyan, Dimitar B Nikolov, Adam W Smith, Bingcheng Wang
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly. Science (New York, N.Y.) (2023)
Amr El Zawily, Frederick S Vizeacoumar, Renuka Dahiya, Sara L Banerjee, Kalpana K Bhanumathy, Hussain Elhasasna, Glinton Hanover, Jessica C Sharpe, Malkon G Sanchez, Paul Greidanus, R Greg Stacey, Kyung-Mee Moon, Ilya Alexandrov, Juha P Himanen, Dimitar B Nikolov, Humphrey Fonge, Aaron P White, Leonard J Foster, Bingcheng Wang, Behzad M Toosi, Nicolas Bisson, Tajib A Mirzabekov, Franco J Vizeacoumar, Andrew Freywald
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yan Xu, Dorothea Robev, Nayanendu Saha, Bingcheng Wang, Matthew B Dalva, Kai Xu, Juha P Himanen, Dimitar B Nikolov
The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism. International journal of molecular sciences 22 (19) (2021)